A b s t r a c t We studied the flow cytometric immunophenotyping (FCI) and genotypic data of 11 specimens from 10 transplant recipients and categorized them based on a scheme for posttransplant lymphoproliferative disorders (PTLDs). Specimens had been analyzed by polymerase chain reaction and/or Southern blot for T-cell and B-cell (immunoglobulin heavy chain and light chain genes) gene rearrangements (BGR). The categories for PTLDs were as follows: 1, 1; 2, 6; and 3, 4. The plasmacytic and polymorphic B-cell hyperplasias (PBCHs) revealed no monoclonal/aberrant cells by FCI or genotypic studies (GS). Three of 4 polymorphic B-cell lymphomas (PBCLs) revealed monoclonal or aberrant (no surface light chain) B cell
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
Post-transplant lymphoproliferative disorders (PTLD) represent a serious complication of solid organ...
Hematopoietic stem cell and solid organ transplant recipients diagnosed with biopsy-confirmed posttr...
Background. Posttransplantation lymphoproliferative disorders (PTLDs) are heterogeneous lymphoid pro...
Posttransplantation lymphoproliferative disorders (PTLDs) represent a serious complication of solid ...
Molecular detection of monoclonality can play an important role in the diagnosis of posttransplantat...
Molecular detection of monoclonality can play an important role in the diagnosis of posttransplantat...
Posttransplantation lymphoproliferative disorders (PTLDs) represent a serious complication of solid ...
AIM: Post-transplant lymphoproliferative disorders (PTLD) represent a serious complication of solid ...
B‐cell post‐transplant lymphoproliferative disorders (PTLD) are classified as early lesions, polymor...
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disease that arises in 2%-...
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid or...
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid or...
BACKGROUND: Posttransplantation lymphoproliferative disorders (PTLDs) are a spectrum of lymphoid pro...
Post-transplant lymphoproliferative disorders (PTLD) derive from antigen-experienced B-cells and rep...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
Post-transplant lymphoproliferative disorders (PTLD) represent a serious complication of solid organ...
Hematopoietic stem cell and solid organ transplant recipients diagnosed with biopsy-confirmed posttr...
Background. Posttransplantation lymphoproliferative disorders (PTLDs) are heterogeneous lymphoid pro...
Posttransplantation lymphoproliferative disorders (PTLDs) represent a serious complication of solid ...
Molecular detection of monoclonality can play an important role in the diagnosis of posttransplantat...
Molecular detection of monoclonality can play an important role in the diagnosis of posttransplantat...
Posttransplantation lymphoproliferative disorders (PTLDs) represent a serious complication of solid ...
AIM: Post-transplant lymphoproliferative disorders (PTLD) represent a serious complication of solid ...
B‐cell post‐transplant lymphoproliferative disorders (PTLD) are classified as early lesions, polymor...
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disease that arises in 2%-...
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid or...
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid or...
BACKGROUND: Posttransplantation lymphoproliferative disorders (PTLDs) are a spectrum of lymphoid pro...
Post-transplant lymphoproliferative disorders (PTLD) derive from antigen-experienced B-cells and rep...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
Post-transplant lymphoproliferative disorders (PTLD) represent a serious complication of solid organ...
Hematopoietic stem cell and solid organ transplant recipients diagnosed with biopsy-confirmed posttr...